康希诺生物

Information Disclosure

Home >Investor Relations >Information Disclosure

H Share

ARTICLES OF ASSOCIATION
INSIDE INFORMATION DETERMINATION OF THE OFFER SIZE AND ISSUE PRICE FOR THE ISSUE OF A SHARES
Monthly Return of Equity Issuer on Movements in Securities
NOTICE OF BOARD MEETING
INSIDE INFORMATION RESEARCH FINDINGS OF PHASE II CLINICAL TRIAL FOR RECOMBINANT NOVEL CORONAVIRUS VACCINE (ADENOVIRUS TYPE 5 VECTOR)
INSIDE INFORMATION PRELIMINARY PRICE CONSULTATION PERIOD OF PROPOSED ISSUE OF A SHARES AND SUMMARY OF PRINCIPAL PROVISIONS OF THE A SHARE PROSPECTUS
INSIDE INFORMATION COOPERATION WITH PFIZER TO PROMOTE MCV4 PRODUCT MENHYCIA
INSIDE INFORMATION COMPLETION OF REGISTRATION OF PROPOSED ISSUE OF A SHARES
INSIDE INFORMATION RECOMBINANT NOVEL CORONAVIRUS VACCINE (ADENOVIRUS TYPE 5 VECTOR) RECEIVED MILITARY SPECIALLY-NEEDED DRUG APPROVAL
Monthly Return of Equity Issuer on Movements in Securities

1 40 41 42 43 44 52